Jobs

272BIO Ltd is an emerging specialist biotechnology company that focuses on developing novel biological therapies for veterinary disease areas. 272BIO is now expanding and will shortly open a new protein science facility at Kent Science Park near Sittingbourne in Kent and is recruiting a dynamic team to engineer and produce the protein biologics that form the basis of high quality, specific and affordable new biological veterinary medicines.

272BIO Ltd is an emerging specialist biotechnology company that focuses on developing novel biological therapies for veterinary disease areas. 272BIO is now expanding and will shortly open a new protein science facility at Kent Science Park near Sittingbourne in Kent and is recruiting a dynamic team to engineer and produce the protein biologics that form the basis of high quality, specific and affordable new biological veterinary medicines.

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

We are looking for a part time (12-20hrs per week) office administrator to organize and coordinate administration duties and office procedures in a small and friendly consultancy company. Your role is to maintain a high levels of organizational effectiveness, communication, and multi-tasks to support a small team.

Responsibilities

• Organize and maintain the office:

 Maintenance the daily office efficiently running, filling,

 Market support for the team

 Liaison with Accountant for the accounting issues, pay the Bills and issue the invoices

bit.bio is an award-winning spinout from the University of Cambridge. Our breakthrough technology combines synthetic and stem cell biology for the precise, efficient and consistent reprogramming of human cells used in research, drug discovery, and cell therapy. At bit.bio, we are passionate about engineering human cells that will enable the medicine of the future. To do this we need talented and curious people who want to make an impact on the future of science and therapeutics.

We are seeking a Discovery DMPK Scientist (Senior Scientist II / Principal Scientist depending on experience). You will be part of a dynamic and innovative environment and will become an integral part of our vision to address patients’ unmet needs while building Britain’s Biggest Biotech. You will use your DMPK expertise and scientific curiosity to solve drug discovery challenges, as part of multi-disciplinary project teams. You will be able to work in state-of-the-art laboratory and modern facilities for optimum collaboration alongside a focused and caring team.

Applications are invited for a Postdoctoral Research Scientist to join the group of Conrad Nieduszynski at the Earlham Institute, based in Norwich, UK.


Background: